table of content
1 Introduction to Research & Analysis Reports
1.1 RNA-Based Therapeutics and Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global RNA-Based Therapeutics and Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RNA-Based Therapeutics and Vaccines Overall Market Size
2.1 Global RNA-Based Therapeutics and Vaccines Market Size: 2021 VS 2028
2.2 Global RNA-Based Therapeutics and Vaccines Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top RNA-Based Therapeutics and Vaccines Players in Global Market
3.2 Top Global RNA-Based Therapeutics and Vaccines Companies Ranked by Revenue
3.3 Global RNA-Based Therapeutics and Vaccines Revenue by Companies
3.4 Top 3 and Top 5 RNA-Based Therapeutics and Vaccines Companies in Global Market, by Revenue in 2021
3.5 Global Companies RNA-Based Therapeutics and Vaccines Product Type
3.6 Tier 1, Tier 2 and Tier 3 RNA-Based Therapeutics and Vaccines Players in Global Market
3.6.1 List of Global Tier 1 RNA-Based Therapeutics and Vaccines Companies
3.6.2 List of Global Tier 2 and Tier 3 RNA-Based Therapeutics and Vaccines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global RNA-Based Therapeutics and Vaccines Market Size Markets, 2021 & 2028
4.1.2 RNA-Based Therapeutics
4.1.3 RNA-Based Vaccines
4.2 By Type - Global RNA-Based Therapeutics and Vaccines Revenue & Forecasts
4.2.1 By Type - Global RNA-Based Therapeutics and Vaccines Revenue, 2017-2022
4.2.2 By Type - Global RNA-Based Therapeutics and Vaccines Revenue, 2023-2028
4.2.3 By Type - Global RNA-Based Therapeutics and Vaccines Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global RNA-Based Therapeutics and Vaccines Market Size, 2021 & 2028
5.1.2 Oncology
5.1.3 Immunology
5.1.4 Ophthalmology
5.1.5 Cardiovascular Diseases
5.1.6 Infectious Diseases
5.1.7 Genetic Diseases
5.1.8 Others
5.2 By Application - Global RNA-Based Therapeutics and Vaccines Revenue & Forecasts
5.2.1 By Application - Global RNA-Based Therapeutics and Vaccines Revenue, 2017-2022
5.2.2 By Application - Global RNA-Based Therapeutics and Vaccines Revenue, 2023-2028
5.2.3 By Application - Global RNA-Based Therapeutics and Vaccines Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global RNA-Based Therapeutics and Vaccines Market Size, 2021 & 2028
6.2 By Region - Global RNA-Based Therapeutics and Vaccines Revenue & Forecasts
6.2.1 By Region - Global RNA-Based Therapeutics and Vaccines Revenue, 2017-2022
6.2.2 By Region - Global RNA-Based Therapeutics and Vaccines Revenue, 2023-2028
6.2.3 By Region - Global RNA-Based Therapeutics and Vaccines Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America RNA-Based Therapeutics and Vaccines Revenue, 2017-2028
6.3.2 US RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.3.3 Canada RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.3.4 Mexico RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe RNA-Based Therapeutics and Vaccines Revenue, 2017-2028
6.4.2 Germany RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.4.3 France RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.4.4 U.K. RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.4.5 Italy RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.4.6 Russia RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.4.7 Nordic Countries RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.4.8 Benelux RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia RNA-Based Therapeutics and Vaccines Revenue, 2017-2028
6.5.2 China RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.5.3 Japan RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.5.4 South Korea RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.5.5 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.5.6 India RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America RNA-Based Therapeutics and Vaccines Revenue, 2017-2028
6.6.2 Brazil RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.6.3 Argentina RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa RNA-Based Therapeutics and Vaccines Revenue, 2017-2028
6.7.2 Turkey RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.7.3 Israel RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.7.4 Saudi Arabia RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.7.5 UAE RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
7 Players Profiles
7.1 Alnylam Pharmaceuticals
7.1.1 Alnylam Pharmaceuticals Corporate Summary
7.1.2 Alnylam Pharmaceuticals Business Overview
7.1.3 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Major Product Offerings
7.1.4 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.1.5 Alnylam Pharmaceuticals Key News
7.2 Arbutus Biopharma
7.2.1 Arbutus Biopharma Corporate Summary
7.2.2 Arbutus Biopharma Business Overview
7.2.3 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Major Product Offerings
7.2.4 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.2.5 Arbutus Biopharma Key News
7.3 Arrowhead Pharmaceuticals
7.3.1 Arrowhead Pharmaceuticals Corporate Summary
7.3.2 Arrowhead Pharmaceuticals Business Overview
7.3.3 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Major Product Offerings
7.3.4 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.3.5 Arrowhead Pharmaceuticals Key News
7.4 BioNTech
7.4.1 BioNTech Corporate Summary
7.4.2 BioNTech Business Overview
7.4.3 BioNTech RNA-Based Therapeutics and Vaccines Major Product Offerings
7.4.4 BioNTech RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.4.5 BioNTech Key News
7.5 CureVac
7.5.1 CureVac Corporate Summary
7.5.2 CureVac Business Overview
7.5.3 CureVac RNA-Based Therapeutics and Vaccines Major Product Offerings
7.5.4 CureVac RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.5.5 CureVac Key News
7.6 Dicerna Pharmaceuticals
7.6.1 Dicerna Pharmaceuticals Corporate Summary
7.6.2 Dicerna Pharmaceuticals Business Overview
7.6.3 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Major Product Offerings
7.6.4 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.6.5 Dicerna Pharmaceuticals Key News
7.7 Regulus Therapeutics
7.7.1 Regulus Therapeutics Corporate Summary
7.7.2 Regulus Therapeutics Business Overview
7.7.3 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Major Product Offerings
7.7.4 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.7.5 Regulus Therapeutics Key News
7.8 Marina Biotech
7.8.1 Marina Biotech Corporate Summary
7.8.2 Marina Biotech Business Overview
7.8.3 Marina Biotech RNA-Based Therapeutics and Vaccines Major Product Offerings
7.8.4 Marina Biotech RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.8.5 Marina Biotech Key News
7.9 MiRagen Therapeutics
7.9.1 MiRagen Therapeutics Corporate Summary
7.9.2 MiRagen Therapeutics Business Overview
7.9.3 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Major Product Offerings
7.9.4 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.9.5 MiRagen Therapeutics Key News
7.10 Moderna Therapeutics
7.10.1 Moderna Therapeutics Corporate Summary
7.10.2 Moderna Therapeutics Business Overview
7.10.3 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Major Product Offerings
7.10.4 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.10.5 Moderna Therapeutics Key News
7.11 Quark Pharmaceuticals
7.11.1 Quark Pharmaceuticals Corporate Summary
7.11.2 Quark Pharmaceuticals Business Overview
7.11.3 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Major Product Offerings
7.11.4 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.11.5 Quark Pharmaceuticals Key News
7.12 Roche
7.12.1 Roche Corporate Summary
7.12.2 Roche Business Overview
7.12.3 Roche RNA-Based Therapeutics and Vaccines Major Product Offerings
7.12.4 Roche RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.12.5 Roche Key News
7.13 Sylentis
7.13.1 Sylentis Corporate Summary
7.13.2 Sylentis Business Overview
7.13.3 Sylentis RNA-Based Therapeutics and Vaccines Major Product Offerings
7.13.4 Sylentis RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.13.5 Sylentis Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
